Both in Pharmaceuticals
Arcus Biosciences vs Prestige Consumer Healthcare
Over the past year RCUS returned −7.1% and PBH returned −18.2%; their daily moves had a correlation of -0.06.
RCUS −7.1% PBH −18.2%Growth of $1, one year, split-adjusted
| Metric | RCUS | PBH |
|---|---|---|
| Price | $18.91 | $49.54 |
| Market cap | $2.41B | $2.35B |
| Today | +5.94% | −0.38% |
| 1 month | −23.6% | +8.6% |
| 6 months | −27.4% | −11.1% |
| Year to date | −20.6% | −19.7% |
| 1 year | −4.1% | −18.3% |
| Revenue growth (YoY) | −74.4% | +6.5% |
| Gross margin | 100.0% | 51.3% |
| Net margin | −222.0% | 11.0% |
| P/E (TTM) | — | 13.6× |
| Price / sales | 20.6× | 2.1× |
| Net cash | $601.0M | -$1.95B |
| Dividend yield | — | — |
| Volatility (60d) | 64.0% | 30.1% |
| Short % of float | 13.6% | 8.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).